TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis

纳米载体 上睑下垂 免疫疗法 宫颈癌 癌症免疫疗法 癌症 癌症研究 医学 肿瘤科 免疫学 内科学 药理学 药品 炎症 炎症体
作者
Huaxi Xu,Danya Zhang,Yu Zhang,Yuxin Chen,Yue Sun,Jie Li,Songwei Tan,Minghao Yin,Rui-Li Wei,Fei Li,Ling Xi
出处
期刊:Theranostics [Ivyspring International Publisher]
卷期号:15 (11): 5420-5439
标识
DOI:10.7150/thno.108357
摘要

Rationale: Pyroptosis, an emerging form of programmed cell death, facilitates the release of tumor antigens and inflammatory factors, which can be leveraged to enhance the efficacy of immune checkpoint blockade (ICB) therapy. However, achieving high-efficiency induction of pyroptosis in cancer cells while minimizing toxicity remains a significant challenge. Methods: In this study, we designed a tumor-targeting peptide TMTP1-modified nanostructured lipid carrier (referred to as TP-NLC) with high loading capacities for gambogic acid (GA) and indocyanine green (ICG). The TMTP1, identified by our research team for its tumor-targeting capabilities, was conjugated to the nanocarrier surface using "click chemistry" to improve the drug delivery efficiency to tumor tissues. The TP-NLC nanocarrier was thoroughly characterized with respect to its morphological attributes, photostability, tumor-targeting capabilities, ability to induce pyroptosis, reactive oxygen species (ROS)-responsive behavior, and anti-tumor efficacy both in vitro and in vivo. Results: GA encapsulated within the TP-NLC nanocarrier, induced pyroptosis in tumor cells, and enhanced the efficacy of ICG-induced pyroptosis under laser irradiation by disrupting intracellular antioxidant systems, realizing that the combination of GA and ICG synergistically induced caspase-3/GSDME-mediated pyroptosis in a ROS-dependent manner. Tumor cells of pyroptosis released cellular contents and tumor antigens, which subsequently promoted the maturation of dendritic cells (DCs), enhanced intratumoral infiltration of CD8+ T cells, initiated systemic antitumor immune response, and augmented the efficiency of PD-1 blockade against both primary and metastatic tumors. Conclusion: The combination of GA and ICG therapy utilizing the constructed nanocarriers presents an attractive therapeutic strategy to trigger pyroptosis and potentiate PD-1 blockade therapy for cervical cancer chemo-immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
橘猫完成签到 ,获得积分10
1秒前
霍三石发布了新的文献求助10
2秒前
五更夜发布了新的文献求助10
2秒前
3秒前
在水一方应助狂野的幻桃采纳,获得30
3秒前
5秒前
KD发布了新的文献求助10
5秒前
wanci应助落寞砖家采纳,获得10
6秒前
6秒前
huadeng完成签到,获得积分10
6秒前
cdercder应助陈丽荣采纳,获得10
6秒前
8秒前
皛宁完成签到 ,获得积分10
8秒前
小涵发布了新的文献求助10
9秒前
轻松棉花糖完成签到 ,获得积分10
9秒前
芝芝完成签到,获得积分10
9秒前
苹果新儿发布了新的文献求助30
11秒前
Bubble完成签到 ,获得积分20
12秒前
啥时候吃火锅完成签到 ,获得积分0
12秒前
13秒前
华仔应助哟喂采纳,获得10
13秒前
SciGPT应助丸子顺利毕业采纳,获得10
14秒前
Lucas应助mumu采纳,获得10
16秒前
123完成签到,获得积分10
16秒前
16秒前
楼下小黑完成签到 ,获得积分10
17秒前
故酒应助科研通管家采纳,获得10
17秒前
卡卡西应助科研通管家采纳,获得10
17秒前
17秒前
英俊的铭应助科研通管家采纳,获得10
17秒前
IMxYang应助科研通管家采纳,获得10
17秒前
乐乐应助科研通管家采纳,获得10
17秒前
科研通AI5应助科研通管家采纳,获得10
17秒前
悠旷完成签到 ,获得积分10
17秒前
17秒前
软语完成签到,获得积分20
18秒前
saaa完成签到 ,获得积分10
18秒前
活力的寻云完成签到 ,获得积分10
19秒前
zho发布了新的文献求助10
19秒前
小涵完成签到,获得积分20
20秒前
高分求助中
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
Hardness Tests and Hardness Number Conversions 300
Knowledge management in the fashion industry 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3816874
求助须知:如何正确求助?哪些是违规求助? 3360257
关于积分的说明 10407382
捐赠科研通 3078228
什么是DOI,文献DOI怎么找? 1690660
邀请新用户注册赠送积分活动 813990
科研通“疑难数据库(出版商)”最低求助积分说明 767924